The insider selling cluster is small relative to market cap and partially liquidity-driven (derivative exercises), so it does not signal a material bearish view. However, the concurrent selling by two C-suite officers (CCO and CPO) within a 3-day window is worth monitoring for any upcoming news or earnings. The non-cash gifts from both co-CEOs are routine and not informative. No immediate trade action warranted, but watch for any 8-K filings or earnings pre-announcements in the next 2-4 weeks.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 14 $157.21entry
- T+1 · 3mo ago +2.84%α +3.31% · $161.67
- T+5 · 3mo ago +8.57%α +9.94% · $170.69
- T+20 · 2mo ago +6.76%α +8.75% · $167.84
- T+60 · 8d ago +0.71%α +3.52% · $158.33
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider selling at Guardant Health (GH) totaling $6.73M in open-market sales over an 8-day window, led by the Chief Commercial Officer ($6.0M) and Chief People Officer ($6.1M across multiple trades). While the dollar amount is modest relative to GH's $22.2B market cap (~0.03%), the cluster includes two C-suite officers selling concurrently, which warrants attention. The sales are partially tied to derivative exercises, suggesting a mix of liquidity-driven and potentially informational selling, but the overall signal is muted by the small proportional size and the presence of non-cash gift transactions from both co-CEOs and the Chief Legal Officer.
Key Financial Metrics
Key Facts
- Total open-market insider sales of $6.73M over 8 days (Aug 5-12, 2026)
- Chief Commercial Officer Chris Freeman sold $6.0M worth of shares on Aug 10
- Chief People Officer Terilyn J. Monroe sold $6.1M across multiple trades on Aug 12
- Both co-CEOs (Helmy Eltoukhy and AmirAli Talasaz) made non-cash gifts of 35K and 75K shares respectively
- Total sales represent ~0.03% of GH's $22.2B market cap
- Sales partially tied to derivative exercises (non-cash events) at strike prices of $28.37 and $110.49
Financial Impact
$6.73M in open-market insider sales, or ~0.03% of market cap
Risk Factors
- Insider selling could precede negative news or a weak earnings report
- Further selling by additional executives could amplify the signal
- Stock at $167-170 range near all-time highs may be vulnerable to profit-taking
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1786665676284 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers